Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Vanda Pharmaceuticals Inc (NASDAQ: VNDA) was $5.13 for the day, up 6.65% from the previous closing price of $4.81. In other words, the price has increased by $6.65 from its previous closing price. On the day, 1.25 million shares were traded.
Ratios:
Our analysis of VNDA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.37 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on October 31, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On July 11, 2024, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $11.
Jefferies Downgraded its Buy to Hold on February 25, 2022, whereas the target price for the stock was revised from $24 to $12.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 05 ’25 when Polymeropoulos Mihael Hristos bought 10,000 shares for $5.02 per share. The transaction valued at 50,200 led to the insider holds 2,285,731 shares of the business.
Polymeropoulos Mihael Hristos bought 10,000 shares of VNDA for $47,050 on Mar 03 ’25. The President and CEO now owns 2,275,731 shares after completing the transaction at $4.71 per share. On Feb 28 ’25, another insider, Polymeropoulos Mihael Hristos, who serves as the President and CEO of the company, bought 10,000 shares for $4.76 each. As a result, the insider paid 47,600 and bolstered with 2,361,730 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 0.56.
Stock Price History:
Over the past 52 weeks, VNDA has reached a high of $6.75, while it has fallen to a 52-week low of $3.71. The 50-Day Moving Average of the stock is 11.28%, while the 200-Day Moving Average is calculated to be 1.38%.
Shares Statistics:
A total of 58.31M shares are outstanding, with a floating share count of 54.24M. Insiders hold about 6.99% of the company’s shares, while institutions hold 74.67% stake in the company.
